Fact CheckerSign in

NCT06465797Completed

Observational Bronchoscopy Video Data Collection Study With Adult Patients

Collecting Imaging Data From Standard-of-care Bronchoscopies for AI-development: a Prospective, Non-interventional Study (Using CE-marked Bronchoscopes)

Source: ClinicalTrials.gov · Last updated 20 Jun 2024

Brief summary (registry, in English)

The primary aim is to develop a software algorithm that has the capacity to detect the normal 18 anatomical structures of the lung by using the position of the scope during the bronchoscopy procedure and using existing bronchoscopy technology.

Status (registry)
Completed
Study type
Observational
Enrollment
115 (actual)
First submitted
10 Jun 2024
Start date
8 Nov 2023
Primary completion date
9 Feb 2024
Lead sponsor
Ambu A/S
Diseases
Lung cancer
NCT number
NCT06465797

What you commit to

  • Study type: Observational
  • Participants enrolled: 115
  • From 8 Nov 2023 to the primary completion date, 9 Feb 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Lack of patient cooperation for bronchoscopy (e.g. patients with mental disorders, dysgnosia, psychological disorder)

Other

  • Patients unable or unwilling to give informed consent

Who the study is looking for

  • Patients indicated for bronchoscopy of central airways as per standard of care
  • Patients of 18 years or above

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Odense University Hospital
Coordinator of this site? Confirm its status
OdenseDenmarkUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.